Literature DB >> 16283146

Molecular features and clinical phenotypes in androgen insensitivity syndrome in the absence and presence of androgen receptor gene mutations.

P M Holterhus1, R Werner, U Hoppe, J Bassler, E Korsch, M B Ranke, H G Dörr, O Hiort.   

Abstract

Androgen insensitivity syndrome (AIS) is characterized by deficient or absent virilization in 46,XY individuals despite normal or even elevated androgen levels. AIS is usually caused by mutations in the androgen receptor (AR) gene. We aimed at contrasting clinical, biochemical, and molecular genetic characteristics of three patients (P1-P3) with clinically evident partial (P1) and complete (P2, P3) AIS with and without AR gene mutations. AR expression was studied in cultured genital skin fibroblasts (GSF) by Western immunoblotting, ligand binding analyses, Northern blotting, semiquantitative reverse transcription-polymerase chain reaction (RT-PCR), and RT-PCR spanning exons 1-8. AR gene DNA sequence was analyzed by single-strand conformation analysis (SSCA), and DNA sequencing. GSF revealed reduced (P1) or absent (P2, P3) ligand binding. Northern blots showed either slightly reduced hybridization of the 10.5-kb AR transcript (P3) or no hybridization (P1, P2), as confirmed by semiquantitative RT-PCR. RT-PCR spanning exons 1-8 detected single AR mRNA bands in P1-P3 excluding splicing errors. Western analyses showed either low (P1) or no (P2, P3) AR protein. While SSCA initially did not reveal any molecular abnormality, sequencing showed a novel CAG (Gln) to TAG (stop) mutation at codon 59 (P3) and a previously described 2-bp deletion at codon 472, leading to a frameshift and premature stop in codon 499 (P2). Intriguingly, P1 showed an unaltered DNA sequence of the coding region of the AR gene including all intron-exon boundaries. In conclusion, patients with clinically evident complete AIS are likely to harbor an AR gene mutation, demanding that the two polymorphic regions must always be included in molecular analyses of the AR gene. Moreover, our data support the concept that in a subset of AIS patients, particularly those with partial AIS, molecular alterations outside the coding region of the AR gene must be presumed.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16283146     DOI: 10.1007/s00109-005-0704-y

Source DB:  PubMed          Journal:  J Mol Med (Berl)        ISSN: 0946-2716            Impact factor:   4.599


  27 in total

1.  Androgen resistance associated with a mutation of the androgen receptor at amino acid 772 (Arg----Cys) results from a combination of decreased messenger ribonucleic acid levels and impairment of receptor function.

Authors:  M Marcelli; W D Tilley; S Zoppi; J E Griffin; J D Wilson; M J McPhaul
Journal:  J Clin Endocrinol Metab       Date:  1991-08       Impact factor: 5.958

2.  Phenotypic diversity and testosterone-induced normalization of mutant L712F androgen receptor function in a kindred with androgen insensitivity.

Authors:  P M Holterhus; G H Sinnecker; O Hiort
Journal:  J Clin Endocrinol Metab       Date:  2000-09       Impact factor: 5.958

Review 3.  Androgen receptor defects: historical, clinical, and molecular perspectives.

Authors:  C A Quigley; A De Bellis; K B Marschke; M K el-Awady; E M Wilson; F S French
Journal:  Endocr Rev       Date:  1995-06       Impact factor: 19.871

4.  Complete androgen insensitivity caused by a splice donor site mutation in intron 2 of the human androgen receptor gene resulting in an exon 2-lacking transcript with premature stop-codon and reduced expression.

Authors:  O J Hellwinkel; K Bull; P M Holterhus; N Homburg; D Struve; O Hiort
Journal:  J Steroid Biochem Mol Biol       Date:  1999-01       Impact factor: 4.292

5.  Immunoreactive AR and genetic alterations in subjects with androgen resistance and undetectable AR levels in genital skin fibroblast ligand-binding assays.

Authors:  Diana M Avila; Carol M Wilson; Neilanjan Nandi; James E Griffin; Michael J McPhaul
Journal:  J Clin Endocrinol Metab       Date:  2002-01       Impact factor: 5.958

6.  Methylation of the androgen receptor minimal promoter silences transcription in human prostate cancer.

Authors:  H Kinoshita; Y Shi; C Sandefur; L F Meisner; C Chang; A Choon; C R Reznikoff; G S Bova; A Friedl; D F Jarrard
Journal:  Cancer Res       Date:  2000-07-01       Impact factor: 12.701

7.  Complete androgen insensitivity caused by a new frameshift deletion of two base pairs in exon 1 of the human androgen receptor gene.

Authors:  B Thiele; W Weidemann; D Schnabel; G Romalo; H U Schweikert; K D Spindler
Journal:  J Clin Endocrinol Metab       Date:  1999-05       Impact factor: 5.958

8.  Functional assessment and clinical classification of androgen sensitivity in patients with mutations of the androgen receptor gene. German Collaborative Intersex Study Group.

Authors:  G H Sinnecker; O Hiort; E M Nitsche; P M Holterhus; K Kruse
Journal:  Eur J Pediatr       Date:  1997-01       Impact factor: 3.183

9.  Partial androgen insensitivity syndrome and t(X;5): are there upstream regulatory elements of the androgen receptor gene?

Authors:  K M Lower; R Kumar; E Woollatt; L Villard; J Gecz; G R Sutherland; D F Callen
Journal:  Horm Res       Date:  2004-09-24

10.  Complete deletion of the androgen receptor gene: definition of the null phenotype of the androgen insensitivity syndrome and determination of carrier status.

Authors:  C A Quigley; K J Friedman; A Johnson; R G Lafreniere; L M Silverman; D B Lubahn; T R Brown; E M Wilson; H F Willard; F S French
Journal:  J Clin Endocrinol Metab       Date:  1992-04       Impact factor: 5.958

View more
  5 in total

1.  Low testosterone levels in pre-term newborns born small for gestational age.

Authors:  R T Scaramuzzo; A Boldrini; S Bertelloni; D Parrini; L Serino; P Ghirri
Journal:  J Endocrinol Invest       Date:  2010-05-05       Impact factor: 4.256

2.  Long-term biochemical evaluation of the androgen receptor pathway in males with disorders of sex development.

Authors:  C Schwentner; J Czyz; J Seibold; T Todenhoefer; S H Alloussi; H Klocker; G Gakis; A Stenzl; M Baka-Ostrowska; C Radmayr
Journal:  World J Urol       Date:  2010-12-15       Impact factor: 4.226

Review 3.  Mendelian genetics of male infertility.

Authors:  Kathleen Hwang; Alexander N Yatsenko; Carolina J Jorgez; Sarmistha Mukherjee; Roopa Lata Nalam; Martin M Matzuk; Dolores J Lamb
Journal:  Ann N Y Acad Sci       Date:  2010-12       Impact factor: 5.691

4.  Apolipoprotein D (APOD) is a putative biomarker of androgen receptor function in androgen insensitivity syndrome.

Authors:  Mahesh Appari; Ralf Werner; Lutz Wünsch; Gunnar Cario; Janos Demeter; Olaf Hiort; Felix Riepe; James D Brooks; Paul-Martin Holterhus
Journal:  J Mol Med (Berl)       Date:  2009-03-30       Impact factor: 4.599

5.  Targeted next-generation sequencing identification of mutations in patients with disorders of sex development.

Authors:  Yanling Dong; Yuting Yi; Hong Yao; Ziying Yang; Huamei Hu; Jiucheng Liu; Changxin Gao; Ming Zhang; Liying Zhou; Xin Yi; Zhiqing Liang
Journal:  BMC Med Genet       Date:  2016-03-15       Impact factor: 2.103

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.